8-K 1 ss414_8k.htm CURRENT REPORT


 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 27, 2016
 
HEARTWARE INTERNATIONAL, INC.
(Exact name of Registrant as specified in its charter)
 
Delaware
 
001-34256
 
26-3636023
(State or other jurisdiction
 
(Commission File
 
(I.R.S. Employer
of incorporation)
 
Number)
 
Identification Number)
 
500 Old Connecticut Path
Framingham, MA
(Address of principal executive
offices)
01701
(Zip code)
 
(508) 739-0950
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 
 
 
 
Item 8.01.
Other Events.
 
On June 27, 2016, HeartWare International, Inc., a Delaware corporation (the “Company”), and Medtronic, Inc., a Minnesota corporation (“Parent”), issued a joint press release announcing the execution of an Agreement and Plan of Merger among the Company, Parent and Medtronic Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent.  A copy of the press release is filed as Exhibit 99.1 hereto and incorporated herein by reference.
 
 
Item 9.01.
Financial Statements and Exhibits.
 
(d) Exhibits.
 
     
Exhibit
No.
  
Description
   
99.1
  
Joint Press Release issued by Medtronic plc and HeartWare International, Inc., dated June 27, 2016.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: June 27, 2016
 
 
 
 
HEARTWARE INTERNATIONAL, INC.
     
 
By:
 
/s/ Lawrence J. Knopf
 
Name:
 
Lawrence J. Knopf
 
Title:
 
Senior Vice President, General Counsel and Secretary
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
     
Exhibit
No.
  
Description
   
99.1
  
Joint Press Release issued by Medtronic plc and HeartWare International, Inc., dated June 27, 2016.